– the leading provider of online annual reports to individual and institutional investors.

Somaxon Pharmaceuticals, Inc.

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the in-licensing, development, and commercialization of proprietary branded products and late-stage product candidates for the treatment medical conditions in the central nervous system therapeutic area. Its product includes Silenor for the treatment of insomnia characterized by difficulty with sleep maintenance.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports